Konica Minolta Precision Medicine has changed its name to Realm IDx to reflect the company's new focus on integrated diagnostics, including the use of genomics, radiology, and pathology, to predict, diagnose, and treat disease.
Realm IDx is not only focused on integrated diagnostics, but also the integration of multimodality data generated by its subsidiary companies, genomics firm Ambry Genetics and radiology and pathology firm Invicro, according to Aaron Elliott, PhD, CEO of the company.
